Feasibility and safety of cellular therapy for in-utero repair of myelomeningocele (CuRe Trial): a first-in-human, phase 1, single-arm study - The Lancet www.thelancet.com/journals/lan...
This first-in-human treatment consisting of allogeneic, live stem cells showed no
cell-related adverse effects. The therapy was assessed as sufficiently safe to proceed
with non-staggered enrolment of...
The Heczey Lab believes that the development of the next-generation of cell therapies will be based on in-vivo (inside the body) genetic engineering of cells which can overcome the immune escape mecha...
seattlechildrens.wd5.myworkdayjobs.com
youtube.com/watch?v=Fd-_...
share.google/PlYzKjubZL0p...
Discussions are ongoing about new academic models. Here is one idea.
Rush for funds to relocate laboratories to Europe is latest hint of a US brain drain.
Some innovative higher-education institutions are reimagining pedagogy by prioritizing local needs over research and international student recruitment. Anna McKie visits one of them.
The US Advisory Committee on Immunization Practices vote on Dec 5 to no longer recommend
the hepatitis B vaccine birth dose, which had ensured that babies exposed to hepatitis
B would not later develo...
www.thelancet.com
Researchers lay bare the human toll of lay-offs, funding cuts and attacks on science one year after the president’s return to the White House.
